Methyl-β-cyclodextrin modified vascular prosthesis: Influence of the modification level on the drug delivery properties in different media

Acta Biomaterialia

Volumn 7, Issue 1, 2011, Pages 304-314

  Blanchemain, N ^a,b   Karrout, Y ^a,b   Tabary, N ^a,c   Neut, C ^a,d   Bria, M ^a   Siepmann, J ^a,b   Hildebrand, H F ^a,b   Martel, B ^a,c  

^a UNIV LILLE   (France)

^b France   (France)

^c UNIVERSITÉ LILLE 1   (France)

^d UNIVERSITÉ DE LILLE   (France)

Author keywords

Antibacterial; Cell viability; Controlled drug release; Surface modification; Vascular grafts

Indexed keywords

ANTIBIOTICS; BIOMATERIALS; CELL CULTURE; CYCLODEXTRINS; ENDOTHELIAL CELLS; ESCHERICHIA COLI; GRAFTING (CHEMICAL); GRAFTS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SURFACE TREATMENT; TARGETED DRUG DELIVERY;

ANTIBACTERIALS; CELL VIABILITY; CONTROLLED DRUG RELEASE; DEGREE OF FUNCTIONALIZATION; HUMAN PLASMAS; METHYL-Β-CYCLODEXTRIN; PROPERTY; SURFACE-MODIFICATION; VASCULAR GRAFTS; VASCULAR PROSTHESIS;

CONTROLLED DRUG DELIVERY;

ANTIBIOTIC AGENT; CIPROFLOXACIN; METHYL BETA CYCLODEXTRIN; POLYMER;

ANTIMICROBIAL ACTIVITY; ARTICLE; BLOOD VESSEL GRAFT; CELL VIABILITY; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; ESCHERICHIA COLI; HUMAN; KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STAPHYLOCOCCUS AUREUS; SUSTAINED RELEASE FORMULATION; TEMPERATURE; TIME;

ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS;

EID: 78049444127     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2010.09.002     Document Type: Article

References (45)

1. T. O'Brien, and J. Collin Prosthetic vascular graft infection Br J Surg 79 1992 1262 1267
2. N. Hennes, W. Sandmann, G. Torsello, H.W. Kniemeyer, and K. Grabitz Infection of a vascular prosthesis - a retrospective analysis of 99 cases Chirurgica 67 1996 37 43
3. R.M. Young, K.J. Cherry, P.M. Davis, P. Gloviczki, T.C. Bower, and J.M. Panneton The results of in situ prosthetic replacement for infected aortic grafts Am J Surg 178 1999 136 140
4. S. O'Connor, P. Andrew, M. Batt, and J.P. Becquemin A systematic review and meta-analysis of treatments for aortic graft infection J Vasc Surg 44 2006 38 45
5. G.P. Clagett, R.J. Valentine, and R.T. Hagino Autogenous aortoiliac/femoral reconstruction from superficial femoral-popliteal veins: feasibility and durability J Vasc Surg 25 1997 255 270
6. A. Nevelsteen, H. Lacroix, and R. Suy Infrarenal aortic graft infection: in situ aortoiliofemoral reconstruction with the lower extremity deep veins Eur J Vasc Endovasc Surg 14A 1997 88 92
7. G.P. Clagett, B.L. Bowers, M.A. Lopez-Viego, M.B. Rossi, R.J. Valentine, and S.I. Myers Creation of a neo-aortoiliac system from lower extremity deep and superficial veins Ann Surg 218 1993 239 249
8. M. Batt, E. Jean-Baptiste, S. O'Connor, P.J. Bouillanne, P. Haudebourg, and R. Hassen-Khodja In-situ revascularisation for patients with aortic graft infection: a single centre experience with silver coated polyester grafts Eur J Vasc Endovasc Surg 36 2008 182 188
9. V. Gahtan, G.E. Esses, D.F. Bandyk, R.T. Nelson, E. Dupont, and J.L. Mills Antistaphylococcal activity of rifampin-bonded gelatin-impregnated Dacron grafts J Surg Res 58 1995 105 110
10. M. Coggia, O. Goeau-Brissonniere, V. Leflon, M.H. Nicolas, and J.C. Pechere Experimental treatment of vascular graft infection due to Staphylococcus epidermidis by in situ replacement with a rifampin-bonded polyester graft Ann Vasc Surg 15 2001 421 429
11. O. Goeau-Brissonniere, D. Fabre, V. Leflon-Guibout, I. Di Centa, M.H. Nicolas-Chanoine, and M. Coggia Comparison of the resistance to infection of rifampin-bonded gelatin-sealed and silver/collagen-coated polyester prostheses J Vasc Surg 35 2002 1260 1263
12. I. Javerliat, O. Goeau-Brissonniere, V. Sivadon-Tardy, M. Coggia, and J.L. Gaillard Prevention of Staphylococcus aureus graft infection by a new gelatin-sealed vascular graft prebonded with antibiotics J Vasc Surg 46 2007 1026 1031
13. D.F. Bandyk, M.L. Novotney, M.R. Back, B.L. Johnson, and D.C. Schmacht Expanded application of in situ replacement for prosthetic graft infection J Vasc Surg 34 2001 411 420
14. D.F. Bandyk Vascular surgical site infection: risk factors and preventive measures Semin Vasc Surg 21 2008 119 123
15. N. Blanchemain, S. Haulon, B. Martel, M. Traisnel, M. Morcellet, and H.F. Hildebrand Vascular PET prostheses surface modification with cyclodextrin coating: development of a new drug delivery system Eur J Vasc Endovasc Surg 29 2005 628 632
16. N. Blanchemain, S. Haulon, F. Boschin, E. Marcon-Bachari, M. Traisnel, and M. Morcellet Vascular prostheses with controlled release of antibiotics - Part 1: surface modifications with cyclodextrin of PET vascular prostheses Biomol Eng 24 2007 149 153
17. N. Blanchemain, T. Laurent, F. Chai, C. Neut, S. Haulon, and V. Krump-Konvalinkova Polyester vascular prostheses modified with cyclodextrins and activated with antibiotics: cytotoxicity and microbiological evaluation Acta Biomater 4 2008 1725 1733
18. B. Martel, M. Morcellet, D. Ruffin, L. Ducoroy, and M. Weltrowski Finishing of polyester fabrics with cyclodextrins and polycarboxylic acids as crosslinking agents J Incl Phen Macrocycl Chem 44 2002 443 446
19. G. Piel, M. Piette, V. Barillaro, D. Castagne, B. Evrard, and L. Delattre Betamethasone-in-cyclodextrin-in-liposome: the effect of cyclodextrins on encapsulation efficiency and release kinetics Int J Pharm 312 2006 75 82
20. T.H. Thi, N. Azaroual, and M.P. Flament Characterization and in vitro evaluation of the formoterol/cyclodextrin complex for pulmonary administration by nebulization Eur J Pharm Biopharm 72 2009 214 218
21. M.A. Tomren, M. Masson, T. Loftsson, and H.H. Tonnesen Studies on curcumin and curcuminoids XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin Int J Pharm 338 2007 27 34
22. L. Belhadj Salem, C. Bosquillon, L.A. Dailey, L. Delattre, G.P. Martin, and B. Evrard Sparing methylation of b-cyclodextrin mitigates cytotoxicity and permeability induction in respiratory epithelial cell layer in vitro J Control Release 136 2009 110 116
23. B. Martel, D. Ruffin, M. Morcellet, M. Weltrowski, and Y. Lechiri Water soluble polymers and gels from polycondensation between CDs and polycarboxylic acids: study of the preparation parameters J Appl Poly Sci 97 2005 433 442
24. Martel B, Morcellet M, Weltrowski M. Cyclodextrin polymers and/or cyclodextrin derivatives with complexing properties and ion exchange properties and method for the production thereof. PCT/FR00/00378, EP 1165621 (2000), US 6660,804 B1 (2003), WO 00/047630.
25. Weltrowski M, Morcellet M, Martel B. Fibre présentant des propriétés de complexation améliorées et des propriétés échangeuses de cations. FR 99/01967 (1999), PCT/FR00/00378(2000), US 09 913,448 (2001).
26. B. Martel, M. Weltrowski, D. Ruffin, and M. Morcellet Polycarboxylic acids as crosslinking agents for grafting cyclodextrins onto cotton and wool fabrics: study of the process parameters J Appl Poly Sci 83 2002 1449 1456
27. V.M.S. Gil, and N.C. Oliveira On the use of the method of continuous variations J Chem Edu 67 1990 473 478
28. K. Connors Binding constants: the measurement of molecular complex stability 1987 Wiley New York
29. T.L. Hwang, and A.J. Shaka Cross relaxation without TOCSY: transverse rotating-frame overhauser effect spectroscopy J Am Chem Soc 114 1992 3157 3159
30. G. Mayer, N. Blanchemain, C. Dupas-Bruzek, V. Miri, M. Traisnel, and L. Gengembre Physico-chemical and biological evaluation of excimer laser irradiated polyethylene terephthalate (PET) surfaces Biomaterials 27 2006 553 566
31. D. Saihi, A. El Achari, A. Ghenaim, and C. Cazé Graft copolymerization of a mixture of perfluorooctyl-2 ethanol acrylic and stearyl methacrylate onto polyester fibers using benzoyl peroxide as initiator Polym Test 21 2002 607 612
32. N. Blanchemain, T. Laurent, S. Haulon, M. Traisnel, C. Neut, and J. Kirkpatrick In vitro study of a PET vascular prosthesis grafted with HPg-cyclodextrins for an anti-infectious drug delivery system J Incl Phen Macrocycl Chem 57 2007 675 681
33. C.P. Scott, and P.A. Higham Antibiotic bone cement for the treatment of Pseudomonas aeruginosa in joint arthroplasty: comparison of tobramycin and gentamicin-loaded cements J Biomed Mater Res 64B 2003 94 98
34. M. Kamberi, K. Tsutsumi, T. Kotegawa, K. Nakamura, and S. Nakano Determination of ciprofloxacin in plasma and urine by HPLC with ultraviolet detection Clin Chem 44 1998 1251 1255
35. Association Franaise de Normalisation. Norme ISO 10993-5/EN 30993-5 - Evaluation biologique des dispositifs médicaux, partie5: Essais concernant la cytotoxicité: Méthodes in vitro.: AFNOR, 1994.
36. J.C. Hornez, A. Lefvre, D. Joly, and H.F. Hildebrand Multiple parameter cytotoxicity index on dental alloys and pure metals Biomol Eng 19 2002 103 118
37. M.E. Frazier, and T.K. Andrews In vitro clonal growth assay for evaluating toxicity of metal salts N. Kharasch, Trace metals in health and disease 1979 Raven Press New York 71 81
38. J. O'Brien, I. Wilson, T. Orton, and F. Pognan Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell toxicity Eur J Biochem 267 2000 5421 5426
39. R. Hamid, Y. Rotshteyn, L. Rabadi, R. Parikh, and P. Bullock Comparison of alamar blue and MTT assays for high through-put screening Toxicol in Vitro 18 2004 703 710
40. F. Chai, A. Ochsenbein, M. Traisnel, R. Busch, J. Breme, and H.F. Hildebrand Improving endothelial cell adhesion and proliferation on titanium by sol-gel derived oxide coating J Biomed Mater Res 92A 2009 754 765
41. C. Jianbin, C. Liang, X. Hao, and M. Dongpin Preparation and study on the solid inclusion complex of ciprofloxacin with β-CD Spectrochim Acta Part A: Mol Biomol Spectrosc 58 2002 2809 2815
42. D. Castagne, M. Fillet, L. Delattre, B. Evrard, B. Nusgens, and G. Piel Study of the cholesterol extraction capacity of b-cyclodextrin and its derivatives, relationships with their effects on endothelial cell viability and on membrane models J Incl Phen Macrocycl Chem 63 2009 225 231
43. D. Castagne, L. Belhadj Salem, L. Delattre, B. Nusgens, and G. Piel Effect of cyclodextrins on the viability of endothelial cells J Incl Phen Macrocycl Chem 57 2007 105 107
44. G. Piel, M. Piette, V. Barillaro, D. Castagne, B. Evrard, and L. Delattre Study of the relationship between lipid binding properties of cyclodextrins and their effect on the integrity of liposomes Int J Pharm 338 2007 35 42
45. N. Blanchemain, S. Haulon, F. Boschin, M. Traisnel, M. Morcellet, and B. Martel Vascular prostheses with controlled release of antibiotics - Part 2: in vivo biological evaluation of vascular prostheses treated by cyclodextrins Biomol Eng 24 2007 143 148